Medications

Ramucirumab in stomach cancer: Added benefit not proven

Ramucirumab (trade name: Cyramza) is a monoclonal antibody, which blocks a receptor, reducing the growth of blood vessels and so reducing blood supply to the tumours. This aims to slow the growth of the tumours. As a so-called ...

Overweight & Obesity

Critics: UK plan to cut child obesity lacks muscle

Britain unveiled a plan Thursday to battle rising child obesity by taxing sodas, urging food manufacturers to cut down on sugar and getting schoolchildren to exercise more.

Health

Court: Law doesn't bar suits against cigarette manufacturers

Cigarette manufacturers aren't immune to lawsuits by smokers who get sick, the state's highest court ruled Monday in a decision that bolsters the case of a smoker who was stricken with laryngeal cancer and won a $28 million ...

page 26 from 40